HIGHLOW
Low-molecular-weight heparin to prevent recurrent VTE in pregnancy: a randomized controlled trial of two doses
Registration:
(Nederlands Trial Register) NTR3894
(Clinicaltrials.gov) NCT01828697
Status:
- Recruitment Completed
- Analyzing Results
Design
Open-label RCT comparing two different doses of low-molecular-weight heparin (LMWH) in pregnant patients with a history of previous venous thromboembolism (VTE)
Participating Sites
Lead Network:
DTN
Countries:
Belgium, Canada, France, Ireland, Norway, The Netherlands, USA,Lead Investigators
Dr. I.M. Bistervels
i.m.bistervels@amc.uva.nl
Subscribe